Skip to main content

Table 4 Parameters predicting retrospective consent

From: Retrospective agreement and consent to neurocritical care is influenced by functional outcome

  Consent to treatment
OR (95% CI)
P value
Univariate analysis   
Demographic data   
   Age 2.800 (0.350-5.808) 0.1057
   Sex: female 3.407 (0.438-8.071) 0.1853
   Mechanical ventilation 3.082 (0.414-22.923) 0.2716
   Funct. status preadmission 1.263 (0.380-4.203) 0.7033
Diagnosis   
   Ischemia 0.440 (0.316-0.612) <0.0001
   ICH 0.441 (0.312-0.625) <0.0001
   SAH 1.408 (0.689-2.880) 0.3482
   Meningoencephalitis 4.019 (1.908-8.470) 0.0003
   Epilepsy 2.627 (1.581-4.363) 0.0002
   GBS/MG 3.560 (1.313-9.650) 0.0126
   Neurodeg./Encephalopathy 0.872 (0.764-1.031) 0.0219
   Cerebral neoplasm 0.623 (0.453-0.824) 0.0038
   Intoxication 1.259 (0.853-1.738) 0.6432
Functional status at 1 year
after discharge
  
   mRS 0.588 (0.538-0.642) <0.0001
Multivariate analysis   
Ischemia 0.294 (0.169-0.509) <0.0001
ICH 0.306 (0.173-0.541) <0.0001
Meningoencephalitis 1.076 (0.426-2.721) 0.8764
Epilepsy 0.568 (0.274-1.179) 0.1289
GBS/MG 0.698 (0.218-2.230) 0.5426
Neurodeg./Encephalopathy 0.821 (0.691-1.368) 0.2574
Cerebral neoplasm 0.572 (0.378-0.911) 0.0097
mRS 0.610 (0.555-0.671) <0.0001
  1. Univariate and multivariate regression analysis to identify predisposing parameters for retrospective consent to neurocritical care. Parameters that reached significance (P < 0.01) are expressed in bold.
  2. OR, odds ratio; CI, confidence interval; Funct, functional; ICH, intracranial hemorrhage; SAH; subarachnoid hemorrhage; GBS, Guillain-Barré syndrome; MG, myasthenia gravis; Neurodeg, neurodegenerative disease; mRS, modified Rankin Scale.